American International Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,396
Closed -$38.3K 3111
2023
Q1
$38.3K Buy
30,396
+605
+2% +$1.16K ﹤0.01% 2781
2022
Q4
$64.6K Sell
29,791
-108
-0.4% -$889 ﹤0.01% 2670
2022
Q3
$358K Buy
29,899
+421
+1% +$5.23K ﹤0.01% 1788
2022
Q2
$247K Sell
29,478
-1,392
-5% -$10.8K ﹤0.01% 2052
2022
Q1
$268K Sell
30,870
-2,173
-7% -$21K ﹤0.01% 2074
2021
Q4
$374K Sell
33,043
-989
-3% -$11.7K ﹤0.01% 1997
2021
Q3
$428K Sell
34,032
-808
-2% -$7.44K ﹤0.01% 1967
2021
Q2
$283 Buy
34,840
+1,817
+6% +$15.8K ﹤0.01% 2288
2021
Q1
$305 Buy
33,023
+87
+0.3% +$877 ﹤0.01% 2125
2020
Q4
$318 Sell
32,936
-945
-3% -$9.31K ﹤0.01% 2019
2020
Q3
$421K Buy
33,881
+3,563
+12% +$47.2K ﹤0.01% 1675
2020
Q2
$394K Buy
30,318
+4,933
+19% +$62K ﹤0.01% 1723
2020
Q1
$258K Sell
25,385
-1,469
-5% -$19.2K ﹤0.01% 1767
2019
Q4
$420K Sell
26,854
-225
-0.8% -$4.53K ﹤0.01% 1790
2019
Q3
$455K Buy
27,079
+14,358
+113% +$286K ﹤0.01% 1721
2019
Q2
$282K Buy
12,721
+5,641
+80% +$108K ﹤0.01% 2021
2019
Q1
$153K Buy
+7,080
New +$148K ﹤0.01% 2357

Other funds holding GOSS

American International Group's GOSS Position: Q2 2023 in Review

American International Group sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 30,396 shares — an estimated $38.3K sold.

American International Group first reported a position in GOSS in Q1 2019 and held it in 17 quarters. The position peaked at $455K in Q3 2019. 99 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • American International Group reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 30,396 Gossamer Bio shares in Q2 2023, an estimated $38.3K.
  • American International Group first reported a position in Gossamer Bio in Q1 2019 and held it in 17 quarters.
  • American International Group's Gossamer Bio position peaked at $455K in Q3 2019.
  • 99 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.